思派健康科技有限公司（股票代码00314）于2026年1月12日发布翌日披露报表。公告显示，公司于交易日回购1,734,600股股份，占回购前已发行股本的约0.232%，最高回购价每股2.82港元，最低回购价每股2.70港元，总金额约483.09万港元。该批回购股份将被持作库藏股。
同日，公司因根据其2017年全球股份计划行使期权，增发6,000股股份，发行价为每股0.4051港元，涉及已发行股本约0.000801%的变动。上述交易完成后，公司持有的已发行股份数增至747,055,514股，库藏股则增至18,496,600股，总股本为765,552,114股。
公告还披露，公司购回授权由股东大会于2025年6月20日通过，授权购回总数为75,022,471股，目前已累计购回4,316,800股，占授权通过日已发行股本的约0.575%。公司确认已遵守相关上市规则与适用法例，本次公告由公司秘书任娜签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.